Cost-effectiveness of universal prophylaxis in pregnancy with prior group B streptococci colonization

Infectious Diseases in Obstetrics and Gynecology

Volumn 2009, Issue , 2009, Pages

  Turrentine, Mark A ^a   Ramirez, Mildred M ^a   Mastrobattista, Joan M ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEPHALOSPORIN; CLINDAMYCIN; ERYTHROMYCIN; PENICILLIN G; VANCOMYCIN; ANTIINFECTIVE AGENT;

ANAPHYLAXIS; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTERIAL COLONIZATION; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; FEMALE; GROUP B STREPTOCOCCAL INFECTION; HUMAN; MAJOR CLINICAL STUDY; PENICILLIN ALLERGY; PREGNANCY; PRIORITY JOURNAL; STREPTOCOCCUS AGALACTIAE; COST; DECISION SUPPORT SYSTEM; ECONOMICS; PREGNANCY COMPLICATION; STREPTOCOCCUS INFECTION;

ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; COSTS AND COST ANALYSIS; DECISION SUPPORT TECHNIQUES; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE;

EID: 73449096388     PISSN: 10647449     EISSN: 10980997     Source Type: Journal    
DOI: 10.1155/2009/934698     Document Type: Article

References (53)

1. Schrag S., Gorwitz R., Fultz-Butts K., Schuchat A., Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC Morbidity and Mortality Weekly Report 2002 51 RR-11 1 22
2. American College of Obstetricians and Gynecologists, ACOG Committee Opinion: number 279, December 2002. Prevention of early-onset group B streptococcal disease in newborns Obstetrics Gynecology 2002 100 6 1405 1412
3. Cheng P.-J., Chueh H.-Y., Liu C.-M., Hsu J.-J., Hsieh T.-T., Soong Y.-K., Risk factors for recurrence of group B streptococcus colonization in a subsequent pregnancy Obstetrics Gynecology 2008 111 3 704 709
4. Turrentine M. A., Ramirez M. M., Recurrence of group B streptococci colonization in subsequent pregnancy Obstetrics Gynecology 2008 112 2, part 1 259 264
5. Edwards R. K., Clark P., Duff P., Intrapartum antibiotic prophylaxis 2: positive predictive value of antenatal group B streptococci cultures and antibiotic susceptibility of clinical isolates Obstetrics Gynecology 2002 100 3 540 544
6. Davis R. L., Hasselquist M. B., Cardenas V., Introduction of the new Centers for Disease Control and Prevention group B streptococcal prevention guideline at a large west coast health maintenance organization American Journal of Obstetrics and Gynecology 2001 184 4 603 610
7. Ottolini M. C., Lundgren K., Mirkinson L. J., Cason S., Ottolini M. G., Utility of complete blood count and blood culture screening to diagnose neonatal sepsis in the asymptomatic at risk newborn Pediatric Infectious Disease Journal 2003 22 5 430 434
8. Rouse D. J., Goldenberg R. L., Cliver S. P., Cutter G. R., Mennemeyer S. T., Fargason C. A. Jr., Strategies for the prevention of early-onset neonatal group B streptococcal sepsis: a decision analysis Obstetrics Gynecology 1994 83 4 483 494
9. Idsoe O., Guthe T., Willcox R. R., de Weck A. L., Nature and extent of penicillin side-reactions, with particular reference to fatalities from anaphylactic shock Bulletin of the World Health Organization 1968 38 2 159 188
10. Kerr J. B., Penicillin allergy: a study of incidence as reported by patients British Journal of Clinical Practice 1994 48 1 5 7
11. Matteson K. A., Lievense S. P., Catanzaro B., Phipps M. G., Intrapartum group B streptococci prophylaxis in patients reporting a penicillin allergy Obstetrics Gynecology 2008 111 2, part 1 356 364
12. Merenstein G. B., Todd W. A., Brown G., Yost C. C., Luzier T., Group B-hemolytic streptococcus: randomized controlled treatment study at term Obstetrics Gynecology 1980 55 3 315 318
13. Allardice J. G., Baskett T. F., Seshia M. M. K., Bowman N., Malazdrewicz R., Perinatal group B streptococcal colonization and infection American Journal of Obstetrics Gynecology 1982 412 6 617 620
14. Morales W. J., Lim D. V., Walsh A. F., Prevention of neonatal group B streptococcal sepsis by the use of a rapid screening test and selective intrapartum chemoprophylaxis American Journal of Obstetrics and Gynecology 1986 155 5 979 983
15. Tuppurainen N., Hallman M., Prevention of neonatal group B streptococcal disease: intrapartum detection and chemoprophylaxis of heavily colonized parturients Obstetrics Gynecology 1989 73 4 583 587
16. Boyer K. M., Gotoff S. P., Prevention of early-onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis The New England Journal of Medicine 1986 314 26 1665 1669
17. Mattoras R., Garcia-Perea A., Omenaca F., Diez-Enciso M., Madero R., Usandizaga J. A., Intrapartum chemoprophylaxis of early-onset group B streptococcal disease European Journal of Obstetrics Gynecology and Reproductive Biology 1991 40 1 57 62
18. Benitz W. E., Gould J. B., Druzin M. L., Preventing early-onset group B streptococcal sepsis: strategy development using decision analysis Pediatrics 1999 103 6, article e76 1 12
19. Schrag S. J., Zell E. R., Lynfield R., A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates The New England Journal of Medicine 2002 347 4 233 239
20. Johannes C. B., Ziyadeh N., Seeger J. D., Tucker E., Reiter C., Faich G., Incidence of allergic reactions associated with antibacterial use in a large, managed care organisation Drug Safety 2007 30 8 705 713
21. Phillips E., Louie M., Knowles S. R., Simor A. E., Oh P. I., Cost-effectiveness analysis of six strategies for cardiovascular surgery prophylaxis in patients labeled penicillin allergic American Journal of Health-System Pharmacy 2000 57 4 339 345
22. Fargason C. A., Peralta-Carcelen M., Rouse D. J., Cutter G. R., Goldenberg R. L., The pediatric costs of strategies for minimizing the risk of early-onset group B streptococcal disease Obstetrics Gynecology 1997 90 3 347 352
23. Balter S., Zell E. R., OBrien K. L., Impact of intrapartum antibiotics on the care and evaluation of the neonate Pediatric Infectious Disease Journal 2003 22 10 853 857
24. Siegel J. E., Weinstein M. C., Russell L. B., Gold M. R., Recommendations for reporting cost-effectiveness analyses Journal of the American Medical Association 1996 276 16 1339 1341
25. Harris R. P., Helfand M., Woolf S. H., Current methods of the U.S. preventive services task force: a review of the process American Journal of Preventive Medicine 2001 20 3, supplement 1 21 35
26. Tejada-Vera B., Sutton P. D., Births, marriages, divorces, and deaths: provisional data for 2007 National Vital Statistics Reports 2008 56 21 1 6
27. Hamilton B. E., Martin J. A., Ventura S. J., Births: preliminary data for 2006 National Vital Statistics Reports 2007 56 7 1 18
28. Martin J. A., Hamilton B. E., Sutton P. D., Ventura S. J., Menacker F., Kirmeyer S., Births: final data for 2004 National Vital Statistics Reports 2006 55 1 1 101
29. Yow M. D., Leeds L. J., Thompson P. K., Mason E. O. Jr., Clark D. J., Beachler C. W., The natural history of group B streptococcal colonization in the pregnant woman and her offspring. I. Colonization studies American Journal of Obstetrics and Gynecology 1980 137 1 34 38
30. Leone R., Conforti A., Venegoni M., Drug-induced anaphylaxis: case/non-case study based on an Italian pharmacovigilance database Drug Safety 2005 28 6 547 556
31. Consumer Price Index Inflation Calculator. Bureau of Labor Statistics, Washington, DC, USA http://www.bls.gov/cpi/
32. Yancey M. K., Duff P., An analysis of the cost-effectiveness of selected protocols for the prevention of neonatal group B streptococcal infection Obstetrics Gynecology 1994 83 3 367 371
33. Mohle-Boetani J. C., Schuchat A., Plikaytis B. D., Smith J. D., Broome C. V., Comparison of prevention strategies for neonatal group B streptococcal infection: a population-based economic analysis Journal of the American Medical Association 1993 270 12 1442 1448
34. Centers for Medicare and Medicaid Services, Fee schedulegeneral information 2008. http://www.cms.hhs.gov/FeeScheduleGenInfo/
35. Greenberg M. B., Cheng Y. W., Hopkins L. M., Stotland N. E., Bryant A. S., Caughey A. B., Are there ethnic differences in the length of labor? American Journal of Obstetrics and Gynecology 2006 195 3 743 748
36. Amerisource Bergen Drug Corporation, The blue book wholesale price average. http://www.amerisourcebergen.com/cp/1/
37. Gencarelli D. M., One pill, many prices: variation in prescription drug prices in selected government programs National Health Policy Forum 2005 807 1 20
38. Mohle-Boetani J. C., Lieu T. A., Ray G. T., Escobar G., Preventing neonatal group B streptococcal disease: cost-effectiveness in a health maintenance organization and the impact of delayed hospital discharge for newborns who received intrapartum antibiotics Pediatrics 1999 103 4 703 710
39. Blank K. R., Cascardi M. A., Kao G. D., The utility of serial complete blood count monitoring in patients receiving radiation therapy for localized prostate cancer International Journal of Radiation Oncology Biology Physics 1999 44 2 317 321
40. McCarthy P. L., Grundy G. W., Spiesel S. Z., Dolan T. F. Jr., Bacteremia in children: an outpatient clinical review Pediatrics 1976 57 6 861 868
41. Lieu T. A., Mohle-Boetani J. C., Ray G. T., Ackerson L. M., Walton D. L., Neonatal group B streptococcal infection in a managed care population Obstetrics Gynecology 1998 92 1 21 27
42. Van den Akker-van Marle M. E., Rijnders M. E. B., van Dommelen P., Cost-effectiveness of different treatment strategies with intrapartum antibiotic prophylaxis to prevent early-onset group B streptococcal disease BJOG 2005 112 6 820 826
43. Glasgow T. S., Speakman M., Firth S., James B., Byington C. L., Young P. C., Clinical and economic outcomes for term infants associated with increasing administration of antibiotics to their mothers Paediatric and Perinatal Epidemiology 2007 21 4 338 346
44. Newborns and mothers health protection act of 1996. 42 USC 1185 601 (Pub L No. 104-204)
45. Kozak L. J., DeFrances C. J., Hall M. J., National hospital discharge survey: 2004 annual summary with detailed diagnosis and procedure data Vital and Health Statistics 2006 13 162 1 218
46. National center for health statistics, Health, United States, 2007 with Chartbook on Trends in the Health of Americans 2007 Hyattsville, Md, USA National Center for Health Statistics
47. Reingold A., Gershman K., Petit S., Perinatal group B streptococcal disease after universal screening recommendationsUnited States, 20032005 Morbidity and Mortality Weekly Report 2007 56 28 701 705
48. Weinstein M. C., Siegel J. E., Gold M. R., Kamlet M. S., Russell L. B., Recommendations of the panel on cost-effectiveness in health and medicine Journal of the American Medical Association 1996 276 15 1253 1258
49. Watt J. P., Schuchat A., Erickson K., Honig J. E., Gibbs R., Schulkin J., Group B streptococcal disease prevention practices of obstetrician- gynecologists Obstetrics Gynecology 2001 98 1 7 13 (Pubitemid 32622756)
50. Sheikh J., Intrapartum anaphylaxis to penicillin in a woman with rheumatoid arthritis who had no prior penicillin allergy Annals of Allergy, Asthma and Immunology 2007 99 3 287 289
51. Spaetgens R., DeBella K., Ma D., Robertson S., Mucenski M., Davies H. D., Perinatal antibiotic usage and changes in colonization and resistance rates of group B streptococcus and other pathogens Obstetrics Gynecology 2002 100 3 525 533
52. Edwards R. K., Clark P., Sistrom C. L., Duff P., Intrapartum antibiotic prophylaxis 1: relative effects of recommended antibiotics on gram-negative pathogens Obstetrics Gynecology 2002 100 3 534 539
53. Schrag S. J., Hadler J. L., Arnold K. E., Martell-Cleary P., Reingold A., Schuchat A., Risk factors for invasive, early-onset Escherichia coli infections in the era of widespread intrapartum antibiotic use Pediatrics 2006 118 2 570 576